Systematic differences in TB treatment outcomes across Brazil by patient- and area-related factors: an analysis of national disease registry data
Open Access
- 5 December 2025
- journal article
- Published by BMJ in BMJ Global Health
- Vol. 10 (12) , e018822
Abstract
Background: Many individuals initiating tuberculosis (TB) treatment do not successfully complete the regimen. Understanding variation in treatment outcomes could reveal opportunities to improve the effectiveness of TB treatment services. Methods: We extracted data on treatment outcomes and patient covariates from Brazil’s National Disease Notification Information System, for new TB patients diagnosed during 2015–2018. We analysed whether or not patients experienced an unsuccessful treatment outcome (any death on treatment, loss to follow-up or treatment failure). We constructed a statistical model (logistic regression with regularised two-way interactions) to predict treatment outcomes as a function of socio-demographic factors, co-prevalent health conditions, health behaviours, membership of vulnerable populations and form of TB disease. We used this model to decompose state- and municipality-level variation in treatment outcomes into differences attributable to patient-level and area-level factors. Results: Treatment outcomes data for 259 449 individuals were used for the analysis. Across Brazilian states, variation in unsuccessful treatment due to patient-level factors was substantially less than variation due to area-level factors, with the difference between best and worst performing states (lowest and highest fraction with unsuccessful treatment, respectively) equal to 7.1 and 13.3 percentage points for patient-level and area-level factors. Similar results were estimated at the municipality level, with 9.3 percentage points separating best and worst performing municipalities according to patient-level factors, and 20.5 percentage points separating best and worst performing municipalities to area-level factors. Results were similar when we analysed loss to follow-up as an outcome. Conclusions: Our analysis revealed substantial variation in TB treatment outcomes across states and municipalities, with only a minority attributable to patient-level factors. Area-level variation likely reflects consequences of differences in health system organisation or socio-environmental factors not reflected in patient-level data. Further research on these factors is needed to identify effective approaches to TB care, reduce geographic disparities and improve treatment outcome.Keywords
Funding Information
- National Institute of Health (R01AI146555)
This publication has 22 references indexed in Scilit:
- Bayesian evidence synthesis to estimate subnational TB incidence: An application in BrazilEpidemics, 2021
- The burden of tuberculosis and attributable risk factors in Brazil, 1990–2017: results from the Global Burden of Disease Study 2017Population Health Metrics, 2020
- Tuberculosis treatment outcomes and associated factors in two states in NigeriaTropical Medicine & International Health, 2020
- Mapping tuberculosis treatment outcomes in EthiopiaBMC Infectious Diseases, 2019
- Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South AfricaPLOS ONE, 2019
- Loss to follow-up among patients receiving anti-tuberculosis treatment, Haiti, 2011–2015Public Health Action, 2018
- Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public–Private CollaborationThe Journal of Infectious Diseases, 2017
- Harnessing the Power of Data to Guide Local Action and End TuberculosisThe Journal of Infectious Diseases, 2017
- A spatial analysis of social and economic determinants of tuberculosis in BrazilHealth & Place, 2014
- Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic ReviewPLOS ONE, 2011